DAPAGLIFLOZIN VERSUS A DIPEPTIDYL PEPTIDASE 4 INHIBITOR (DPP4) BOTH ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM): IMPACT ON HEALTH, QUALITY OF LIFE AND COSTS IN THE TURKISH CLINICAL SETTING


Creative Commons License

Malhan S., Guler S., Yetkin I., Ignacio T. J. , Verheggen B., Charokopou M.

VALUE IN HEALTH, cilt.18, sa.7, 2015 (SCI İndekslerine Giren Dergi) identifier